KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $992.0 million.

  • Medtronic's Gains from Investment Securities rose 541.98% to $992.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $1.9 billion, marking a year-over-year increase of 167.84%. This contributed to the annual value of $1.8 billion for FY2025, which is 1214.55% up from last year.
  • According to the latest figures from Q4 2025, Medtronic's Gains from Investment Securities is $992.0 million, which was up 541.98% from $402.0 million recorded in Q3 2025.
  • Medtronic's Gains from Investment Securities' 5-year high stood at $1.2 billion during Q4 2023, with a 5-year trough of -$135.0 million in Q3 2023.
  • For the 5-year period, Medtronic's Gains from Investment Securities averaged around $412.2 million, with its median value being $335.0 million (2021).
  • As far as peak fluctuations go, Medtronic's Gains from Investment Securities tumbled by 15192.31% in 2023, and later soared by 39185.19% in 2024.
  • Over the past 5 years, Medtronic's Gains from Investment Securities (Quarter) stood at $366.0 million in 2021, then soared by 53.28% to $561.0 million in 2022, then surged by 121.93% to $1.2 billion in 2023, then decreased by 24.42% to $941.0 million in 2024, then increased by 5.42% to $992.0 million in 2025.
  • Its Gains from Investment Securities stands at $992.0 million for Q4 2025, versus $402.0 million for Q3 2025 and $304.0 million for Q2 2025.